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Introduction
Benign peripheral nerve tumours of the oral
cavity include schwannoma, neurofibroma, nerve
sheath myxoma, mucosal neuroma, traumatic
neuroma and granular cell tumour [1, 2].
Schwannoma (neurilemmoma) is an encapsulated
perineural tumour originating from Schwann cells
associated with motor, sensory or autonomic
peripheral nerves [3]. There is no age or gender
predilection [4]. Schwannomas are occasionally
found in the region of the head and neck but oral
localization is uncommon (about 10% of head and
neck schwannomas) [1]. The most frequently
involved regions are, in decreasing order: mobile
portion of the tongue, palate, cheek mucosa, lips
and gingiva [1]. The tumour shows two different
histological patterns, Antoni type A and Antoni
type B [4].
Routine histopathological procedure is usually
sufficient to differentiate benign neural tumours.
However, some cases require more data to
establish the proper diagnosis. This case report
documents an uncommon presentation of a large
schwannoma in the cheek mucosa and
comprehensively describes immunohistochemical
properties of the tumour.
Material and methods
A fifty-five-year-old male complained of a large
tumour growing on the inner side of the left
cheek. The patient reported a 20-year history
of gradually increasing difficulty in chewing
caused by the mass. No symptoms of generalized
neurofibromatosis were noticed. Functionality
of face muscles was normal. No sensory
abnormalities in the region supplied by
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Schwannoma is a benign tumour originating from Schwann cells forming
sheaths of peripheral nerves. Its location in the oral cavity, and particularly in
the cheek, is very rare. A large tumour (5 cm) was surgically removed from 
the left cheek of a fifty-five-year-old man and pathological examination revealed
schwannoma with Antoni A and B patterns. The tumour was investigated
using immunofluorescence and histochemical stainings. It showed positive
immunostaining for S-100, PGP 9.5, NSE, collagen IV, laminin, merosin and
vimentin. No immunofluorescence for GFAP, NPY and CGRP was observed.
Cells of the macrophage family (CD68-immunopositive) were scattered in 
the connective tissue. Neither B (CD20+) nor T (CD3+, CD8+) lymphocytes
were found. The capillary network was revealed by CD34 immunostaining.
SMA immunoreactivity was observed in walls of larger blood vessels but not in
tumour cells. The tumour contained numerous mast cells visualized by thionin
staining and an abundance of collagen fibres revealed by picrosirius red.
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the trigeminal nerve were observed prior to
surgery. The tumour was removed under local
anaesthesia after dissection of the mucosa
of the cheek. During surgery no definitive nerve
of origin was identified. The lesion was hard,
encapsulated, 50 mm in diameter. Material was
fixed in 4% buffered paraformaldehyde. One part
was routinely processed and paraffin sections were
stained with Meyer’s haematoxylin and eosin for
general morphology, with thionin for mast cells,
with alcian blue for matrix proteoglycans and
with picrosirius red for collagen fibres. The se-
cond part of the tumour was snap-frozen and 
10 µm-thick cryosections were subjected to
indirect immunofluorescence, applying primary
rabbit or mouse antibodies (Table I). For
visualization of the reaction, Cy3-conjugated goat
anti-rabbit antiserum (Jackson IR, West Grove,
PA; 111-165-144; diluted 1 : 600) or Cy3-con-
jugated goat anti-mouse antiserum (Jackson IR;
115-165-146; diluted 1 : 600) was used (this step
was omitted in the case of C y 3-conjugated
anti-smooth muscle actin antibody). In
the controls, the primary or secondary antibodies
were replaced by noni-mmune serum. An
Olympus BX50 bright field/epifluorescence
microscope (Olympus, Tokyo, Japan) equipped
with U-MNG filter set was used to examine
histologically stained and immunostained
sections, respectively. Images were recorded using
an Olympus DP71 digital CCD camera.
Results
The patient has been followed up for 12 months.
Discrete sensory insufficiency has persisted in
the region of the left cheek over the tumour site
half a year after surgery. No motor disturbances
or other complaints were observed.
Histopathological examination of the tumour
revealed schwannoma surrounded by thick
connective tissue capsule and containing spindle-
shaped cells forming typical Antoni A and Antoni
B zones. Antoni A tissue was dominant in
the lesion, showing characteristic palisade
arrangement and Verocay bodies. Interestingly,
also neurofibroma-like regions were occasionally
seen (Fig. 1). Sirius red staining revealed an
abundance of collagen fibres in the stroma
of the tumour. Moreover, collagen was present
not only in the capsule and connective tissue but
also within Antoni A and Antoni B areas. In
thionin-stained sections, numerous mast cells were
visualized in the connective tissue areas
of the lesion. There was weak and uniform alcian
blue staining in the tumour. The tumour cells
showed positive immunostaining for S-100 protein
in both schwannoma and neurofibroma-like areas.
Virtually all spindle-shaped cells were S-100
immunopositive (Fig. 2). Similarly, PGP 9.5 and
NSE were abundantly present and they displayed
a similar distribution pattern in neoplastic cells
(Figs 3, 4). However, NSE was also present in
a population of oval cells in the connective tissue
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Table I. List of primary antibodies used in the study
ANTIGEN HOST/TYPE DILUTION VENDOR; CATALOGUE NUMBER
S-100 mouse/monoclonal 1 : 100 Chemicon, Temecula, CA; MAB079-1
PGP 9.5 rabbit/polyclonal 1 : 2000 Chemicon; AB1761
NSE mouse/monoclonal 1 : 200 Novocastra, Newcastle, UK;
NCL-NSE-435
NPY rabbit/polyclonal 1 : 2000 Biomol (Europe), Exeter, UK, NA1233
CGRP rabbit/polyclonal 1 : 4000 Chemicon; AB5920 
GFAP mouse/monoclonal 1 : 50 DAKO, Glostrup, Denmark; M0761
CD3 mouse/monoclonal 1 : 100 Novocastra; NCL-CD3-565
CD8 mouse/monoclonal 1 : 1 Chemicon; ICHR2114-6 
CD68 mouse/monoclonal 1 : 1 Chemicon; ICHR2113-6
CD20 mouse/monoclonal 1 : 100 Novocastra; NCL-CD20-7D1
CD34 mouse/monoclonal 1 : 50 Novocastra; NCL-END
Collagen IV mouse/monoclonal 1 : 100 Novocastra; NCL-COLL-IV
Laminin rabbit/polyclonal 1 : 50 Sigma, St. Louis, MO; L9393
Merosin mouse/monoclonal 1 : 4000 Chemicon; MAB1922
Vimentin mouse/monoclonal 1 : 100 Novocastra; NCL-VIM
SMA-Cy3 mouse/monoclonal 1 : 800 Sigma; C6198
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(Fig. 3). No immunofluorescence for GFAP, NPY
and CGRP was observed. Numerous cells
of the macrophage family (CD68-immuno-
positive) were scattered in the connective 
tissue (Fig. 5). Neither B (CD20+) nor T 
(CD3+, CD8+) lymphocytes could be seen in
the tumour. CD34 immunoreactivity was
observed mainly in the stroma, displaying
a characteristic appearance of capillary meshwork
(Fig. 6). Smooth muscle actin (SMA) immuno-
Fig. 1. Haematoxylin and eosin staining of the tumour
displaying mostly Antoni A component. Neurofibroma
pattern marked with arrow
Fig. 3. Positive immunohistochemical staining for PGP 9.5
in the tumour
Fig. 4. Immunohistochemical staining for NSE showing
positive cells in the connective tissue (arrows)
Fig. 2. Positive immunohistochemical staining for S-100
protein in the tumour
Fig. 5. Macrophages visualized by CD68
immunohistochemistry in the connective tissue
Fig. 6. Microvasculature of the tumour demonstrated by
CD34 immunostaining
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reactivity was not found in tumour cells, but
larger blood vessels were labelled. Vimentin
immunostaining was expressed mostly in areas
of the connective tissue. Immunofluorescence for
collagen IV was relatively weak in Antoni A and
B areas; much higher immunoreactivity was
observed in the capsule and in blood vessels. The
tumour showed positive immunostaining for
laminin (Fig. 7) as well as merosin (Fig. 8),
although laminin was more widespread and
abundant judging from reaction intensity.
Discussion
Schwannoma, particularly a tumour of this
size, is a very rare finding in the discussed site [1].
The present paper reports for the first time results
of immunocytochemical assays employing
a broad panel of primary monoclonal and
polyclonal antibodies in order to describe
the biological nature of the tumour. Selected
histochemical stainings were applied to further
characterize components of the extracellular
matrix in the tumour and to detect mast cells. 
Positive immunostaining for S-100 protein is
a characteristic feature of schwannomas. This
protein is expressed by Schwann cells, but not by
perineurial cells and endoneurial fibroblasts. 
The pan-neuronal marker protein gene product 
9.5 (PGP 9.5) is localized in both central and
peripheral neurons and it has also been found in
neuroendocrine cells. Zarfoss et al. obtained
positive immunostaining for PGP 9.5 in 7 out of
9 canine anterior uveal spindle cell tumours
(consistent with human schwannomas) [5]. In
the tumour presented in this study, PGP 9.5
immunoreactivity was also confirmed in tumour
cells. It is interesting that a typical marker
of nerve and neuroendocrine cells is expressed by
neoplasms originating from Schwann cells. NSE
immunoreactivity, observed within the discussed
tumour, was also seen in some cells located in
the connective tissue, probably belonging to
the macrophage family, particularly in view
of the fact that CD68-positive cells were
recognized in this location and NSE was reported
to be produced and released by activated
macrophages [7]. NPY and CGRP are phy-
siological neuronal markers, characteristic
of autonomic and sensory nerve fibres,
respectively. They were not seen in the described
schwannoma, making it impossible to determine
the origin of the tumour from a specific type
of peripheral nerve. The apparent absence
of nerve fibres within the tumour is typical for
schwannomas, since they displace nerve bundles
rather than invade the nerve, the latter feature
being characteristic for neurofibromas. However,
axons in schwannomas were occasionally detected
by neurofilament immunoreactivity and
Bielschowsky silver impregnation [2, 6]. Infla-
mmatory and immune cells are present in
the microenvironment of most, if not all,
tumours. They include macrophages, mast cells
and T lymphocytes. In our case we showed
numerous mast cells which have long been known
to drive angiogenesis as well as to promote new
blood vessel formation and tumour growth. In
addition, tumours are frequently infiltrated by
regulatory T cells, which suppress both adaptive
and innate immune responses [8]. However, 
B (CD20+) and T (CD3+, CD8+) lymphocytes
were not seen in the tumour described in this
study. The presence of CD68-positive
macrophages distributed in the connective tissue
of the investigated tumour has also been
described in schwannomas by Chrysomali and
coworkers, who reported CD68-positive cells
being more numerous in Antoni B than Antoni
A regions [2].
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Fig. 7. Positive immunostaining for laminin in Antoni A Fig. 8. Positive immunostaining for merosin in Antoni A
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Components of the basal lamina, including
laminin, merosin and type IV collagen, are
synthesized by Schwann cells and are therefore
present in schwannomas [9]. Expression of type
IV collagen is generally a feature of all benign
neural tumours and schwannomas show
immunoreactivity for collagen type IV in
association with most of the tumour cells [2]. 
The capsule around schwannomas also shows
positive immunostaining for collagen type IV and
these findings were confirmed in our case [2, 10].
In human Schwann cell neoplasms, laminin was
seen in all tumour cell basement membranes. In
contrast, merosin was found exclusively in areas
where schwannoma cells were in contact with
stromal or vascular tissue [11]. It is present almost
exclusively in highly differentiated Schwann cell
neoplasms and its distribution is more restricted
than that of laminin, which was confirmed in
the tumour described in this study. 
CD34 is typically expressed by bone-marrow
stem cells and endothelial cells but it has also been
detected in dendritic/spindle cells in mucosa,
dermis, and in endoneurium [2]. In the tumour
studied, CD34 immunostaining was consistently
present only in endothelial cells of the capillary
vessels. All schwannomas express vimentin
immunoreactivity, paradoxically suggesting
mesenchymal phenotype of the tumour, although
Schwann cells originate from the neural crest.
SMA immunoreactivity is typical for smooth
muscle cells. All canine anterior uveal spindle cell
tumours were negative for SMA [5]. In our
tumour, SMA immunoreactivity was only found
in the walls of large blood vessels, reflecting
the presence of vascular smooth myocytes.
In the present study we used histochemical
stainings to characterize components
of the tumour stroma. Collagen fibres (visualized
by picrosirius red) were present not only in
the capsule and larger connective tissue areas, but
formed a dense stroma throughout the tumour.
Matrix proteoglycans (stained with alcian blue)
were less abundant. Small areas showing
a neurofibroma-like pattern were observed in
the studied tumour. Similar findings were
reported by Nascimento and coworkers [6].
Moreover, hybrid tumours displaying both
patterns, even with prevalence of neurofibroma,
were also described [10].
Although there are characteristic histological
features that allow one to distinguish between
morphologically similar lesions, such as
leiomyoma, schwannoma, benign fibrohistio-
cytoma, neurofibroma and myoepithelioma
of the salivary glands, the differential diagnosis
can be difficult in the case of small or fragmented
biopsies [12]. Thus, immunohistochemistry and
other stainings seem to be a valuable tool in
pathomorphological diagnosis of benign oral
tumours. 
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